Ret Proto-Oncogene anticorps (AA 361-459)
Aperçu rapide pour Ret Proto-Oncogene anticorps (AA 361-459) (ABIN2350381)
Antigène
Voir toutes Ret Proto-Oncogene (RET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 361-459
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- RET (CDHF12, CDHR16, PTC, RET51, Proto-oncogene Tyrosine-protein Kinase Receptor Ret, Cadherin Family Member 12, Proto-oncogene c-Ret, Soluble RET Kinase Fragment, Extracellular Cell-membrane Anchored RET Cadherin 120kD Fragment)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Partial recombinant corresponding to aa361-459, from human RET (AAH03072) with GST tag. MW of the GST tag alone is 26kD.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- Ret Proto-Oncogene (RET)
-
Autre désignation
- RET
-
Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Antigène
-